They administered FEC-100 (5-fluorouracil, epirubicin, cyclophosphamide) at a 20% reduced dose, combined with G-CSF and cyclosporin A. Although she developed FN twice during the period, no focus of infection was identified. This evidence concerns the gene CSF3 and infection.